activity
20242026
collaborators

12 papers

q-bio.BM2026

End-to-End Reverse Screening Identifies Protein Targets of Small Molecules Using HelixFold3

Shengjie Xu, Xianbin Ye, Mengran Zhu +3

Identifying protein targets for small molecules, or reverse screening, is essential for understanding drug action, guiding compound repurposing, predicting off-target effects, and…

q-bio.BM2025

Reshaping Biomolecular Structure Prediction through Strategic Conformational Exploration with HelixFold-S1

Lihang Liu, Yang Liu, Xianbin Ye +6

Generating large ensembles of candidate conformations is standard for improving biomolecular structure prediction. Yet aimless sampling is inefficient and costly, producing many re…

q-bio.BM2025

HelixVS: Deep Learning-Enhanced Structure-Based Platform for Screening and Design

Shanzhuo Zhang, Xianbin Ye, Donglong He +3

Drug discovery through virtual screening (VS) has become a popular strategy for identifying hits against protein targets. Alongside VS, molecular design further expands accessible…

physics.chem-ph2025

BioScore: A Foundational Scoring Function For Diverse Biomolecular Complexes

Yuchen Zhu, Jihong Chen, Yitong Li +9

Structural assessment of biomolecular complexes is vital for translating molecular models into functional insights, shaping our understanding of biology and aiding drug discovery.…

q-bio.BM2025

HelixDesign-Antibody: A Scalable Production-Grade Platform for Antibody Design Built on HelixFold3

Jie Gao, Jing Hu, Shanzhuo Zhang +5

Antibody engineering is essential for developing therapeutics and advancing biomedical research. Traditional discovery methods often rely on time-consuming and resource-intensive e…

q-bio.BM2025

HelixDesign-Binder: A Scalable Production-Grade Platform for Binder Design Built on HelixFold3

Jie Gao, Jun Li, Jing Hu +5

Protein binder design is central to therapeutics, diagnostics, and synthetic biology, yet practical deployment remains challenging due to fragmented workflows, high computational c…